Pomanda estimates the enterprise value of DERMAPURE LIMITED at £842.9k based on a Turnover of £1.4m and 0.6x industry multiple (adjusted for size and gross margin).
dermapure limitedEstimated Valuation
£0
Pomanda estimates the enterprise value of DERMAPURE LIMITED at £0 based on an EBITDA of £-160.1k and a 4.14x industry multiple (adjusted for size and gross margin).
dermapure limitedEstimated Valuation
£1.5m
Pomanda estimates the enterprise value of DERMAPURE LIMITED at £1.5m based on Net Assets of £681.1k and 2.24x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Dermapure LimitedOverview
Dermapure Limited is a live company located in weybridge, KT13 0YF with a Companies House number of 05660388. It operates in the other professional, scientific and technical activities n.e.c. sector, SIC Code 74909. Founded in December 2005, it's largest shareholder is
gary matthew baulch
with a 50% stake. Dermapure Limited is a mature,
small sized company, Pomanda has estimated its turnover at
£1.4m with
declining
growth in recent years.
Pomanda's financial health check has awarded Dermapure Limited a 4 rating. We use a traffic light system to show it exceeds the industry average on 3 measures and has 4 areas for improvement. Company Health Check FAQs
Health Rating4out of 5
3 Strong
5 Regular
4 Weak
Size
annual sales of £1.4m, make it smaller than the average company (£2.1m)
£1.4m - Dermapure Limited
£2.1m - Industry AVG
Growth
3 year (CAGR) sales growth of -8%, show it is growing at a slower rate (10%)
-8% - Dermapure Limited
10% - Industry AVG
Production
with a gross margin of 47.3%, this company has a comparable cost of product (47.3%)
47.3% - Dermapure Limited
47.3% - Industry AVG
Profitability
an operating margin of -13.7% make it less profitable than the average company (5.5%)
-13.7% - Dermapure Limited
5.5% - Industry AVG
Employees
with 16 employees, this is similar to the industry average (18)
16 - Dermapure Limited
18 - Industry AVG
Pay Structure
on an average salary of £51.7k, the company has an equivalent pay structure (£51.7k)
£51.7k - Dermapure Limited
£51.7k - Industry AVG
Efficiency
resulting in sales per employee of £87.2k, this is less efficient (£119.4k)
£87.2k - Dermapure Limited
£119.4k - Industry AVG
Debtor Days
it gets paid by customers after 44 days, this is near the average (53 days)
44 days - Dermapure Limited
53 days - Industry AVG
Creditor Days
its suppliers are paid after 114 days, this is slower than average (31 days)
114 days - Dermapure Limited
31 days - Industry AVG
Stock Days
it holds stock equivalent to 30 days, this is in line with average (31 days)
30 days - Dermapure Limited
31 days - Industry AVG
Cash Balance
has cash to cover current liabilities
for 142 weeks, this is more cash available to meet short term requirements (26 weeks)
142 weeks - Dermapure Limited
26 weeks - Industry AVG
Debt Level
it has a ratio of liabilities to total assets of 26.2%, this is a lower level of debt than the average (52.6%)
26.2% - Dermapure Limited
52.6% - Industry AVG
DERMAPURE LIMITED financials
EXPORT
Dermapure Limited's latest turnover from June 2024 is estimated at £1.4 million and the company has net assets of £681.1 thousand. According to their latest financial statements, Dermapure Limited has 16 employees and maintains cash reserves of £632.4 thousand as reported in the balance sheet.
Data source:Companies House, Pomanda Estimates
Jun 2024
Jun 2023
Jun 2022
Jun 2021
Jun 2020
Jun 2019
Jun 2018
Jun 2017
Jun 2016
Jun 2015
Jun 2014
Jun 2013
Jun 2012
Jun 2011
Jun 2010
Turnover
1,395,209
1,811,333
1,776,144
1,775,865
1,374,595
1,498,175
1,350,592
1,505,563
1,099,484
2,087,549
2,016,055
2,156,845
2,004,877
1,510,451
1,536,717
Other Income Or Grants
Cost Of Sales
735,893
1,002,356
1,004,684
989,980
758,242
798,094
722,109
755,388
536,069
1,033,333
1,020,907
1,072,260
985,473
758,526
737,337
Gross Profit
659,316
808,977
771,460
785,885
616,353
700,081
628,483
750,175
563,416
1,054,216
995,148
1,084,585
1,019,403
751,925
799,380
Admin Expenses
850,085
862,095
625,778
491,184
488,950
693,019
639,461
682,822
482,264
1,033,332
980,419
1,007,090
975,827
662,325
688,590
Operating Profit
-190,769
-53,118
145,682
294,701
127,403
7,062
-10,978
67,353
81,152
20,884
14,729
77,495
43,576
89,600
110,790
Interest Payable
1,525
1,525
Interest Receivable
34,962
35,925
9,511
591
330
2,195
1,382
767
1,673
772
201
453
391
79
Pre-Tax Profit
-155,807
-17,193
155,193
293,767
126,207
9,257
-9,596
68,120
82,825
21,656
14,930
77,948
43,967
89,680
110,790
Tax
-29,487
-55,816
-23,979
-1,759
-12,943
-16,565
-4,331
-3,135
-17,928
-10,552
-23,317
-31,021
Profit After Tax
-155,807
-17,193
125,706
237,951
102,228
7,498
-9,596
55,177
66,260
17,325
11,795
60,020
33,415
66,363
79,769
Dividends Paid
Retained Profit
-155,807
-17,193
125,706
237,951
102,228
7,498
-9,596
55,177
66,260
17,325
11,795
60,020
33,415
66,363
79,769
Employee Costs
826,932
794,227
704,000
539,000
920,197
856,536
837,197
725,926
430,181
824,104
807,912
862,948
756,211
579,089
609,818
Number Of Employees
16
16
15
12
21
19
19
17
10
19
19
21
19
15
16
EBITDA*
-160,095
-14,217
173,971
312,037
192,122
29,092
4,772
67,353
109,953
47,214
43,523
100,391
60,987
103,732
120,540
* Earnings Before Interest, Tax, Depreciation and Amortisation
Jun 2024
Jun 2023
Jun 2022
Jun 2021
Jun 2020
Jun 2019
Jun 2018
Jun 2017
Jun 2016
Jun 2015
Jun 2014
Jun 2013
Jun 2012
Jun 2011
Jun 2010
Tangible Assets
59,470
106,400
140,433
7,128
191,517
260,443
31,328
20,719
44,367
50,100
62,315
80,122
50,921
43,143
40,403
Intangible Assets
Investments & Other
Debtors (Due After 1 year)
Total Fixed Assets
59,470
106,400
140,433
7,128
191,517
260,443
31,328
20,719
44,367
50,100
62,315
80,122
50,921
43,143
40,403
Stock & work in progress
60,768
115,604
260,785
257,678
237,008
179,126
232,429
260,952
205,665
182,785
166,384
252,862
199,361
164,470
117,560
Trade Debtors
170,236
282,112
230,343
217,629
89,120
176,397
133,295
214,512
127,236
280,845
330,825
303,208
265,502
218,567
234,848
Group Debtors
Misc Debtors
165,978
103,508
32,197
34,281
31,955
Cash
632,418
699,457
737,535
784,191
397,228
261,825
323,462
229,497
384,284
284,758
24,200
56,303
124,752
31,699
misc current assets
total current assets
863,422
1,097,173
1,228,663
1,259,498
889,334
720,856
721,383
739,242
749,140
748,388
521,409
612,373
589,615
414,736
352,408
total assets
922,892
1,203,573
1,369,096
1,266,626
1,080,851
981,299
752,711
759,961
793,507
798,488
583,724
692,495
640,536
457,879
392,811
Bank overdraft
50,000
Bank loan
Trade Creditors
231,292
331,827
454,449
538,321
247,477
265,412
239,632
250,135
301,062
521,162
317,734
423,161
443,881
302,164
306,284
Group/Directors Accounts
other short term finances
hp & lease commitments
45,164
49,482
9,340
5,696
7,953
other current liabilities
135,392
115,235
112,522
112,006
138,962
total current liabilities
231,292
331,827
454,449
538,321
478,033
430,129
361,494
367,837
447,977
521,162
317,734
423,161
443,881
302,164
306,284
loans
hp & lease commitments
112,464
163,044
10,589
1,900
10,483
Accruals and Deferred Income
other liabilities
10,489
34,828
60,636
8,539
14,528
29,667
17,008
9,581
6,756
provisions
total long term liabilities
10,489
34,828
60,636
112,464
163,044
10,589
1,900
10,483
8,539
14,528
29,667
17,008
9,581
6,756
total liabilities
241,781
366,655
515,085
538,321
590,497
593,173
372,083
369,737
458,460
529,701
332,262
452,828
460,889
311,745
313,040
net assets
681,111
836,918
854,011
728,305
490,354
388,126
380,628
390,224
335,047
268,787
251,462
239,667
179,647
146,134
79,771
total shareholders funds
681,111
836,918
854,011
728,305
490,354
388,126
380,628
390,224
335,047
268,787
251,462
239,667
179,647
146,134
79,771
Jun 2024
Jun 2023
Jun 2022
Jun 2021
Jun 2020
Jun 2019
Jun 2018
Jun 2017
Jun 2016
Jun 2015
Jun 2014
Jun 2013
Jun 2012
Jun 2011
Jun 2010
Operating Activities
Operating Profit
-190,769
-53,118
145,682
294,701
127,403
7,062
-10,978
67,353
81,152
20,884
14,729
77,495
43,576
89,600
110,790
Depreciation
30,674
38,901
28,289
17,336
64,719
22,030
15,750
28,801
26,330
28,794
22,896
17,411
14,132
9,750
Amortisation
Tax
-29,487
-55,816
-23,979
-1,759
-12,943
-16,565
-4,331
-3,135
-17,928
-10,552
-23,317
-31,021
Stock
-54,836
-145,181
3,107
20,670
57,882
-53,303
-28,523
55,287
22,880
16,401
-86,478
53,501
34,891
46,910
117,560
Debtors
-111,876
51,769
12,714
-37,469
-24,807
114,413
-83,301
89,602
-121,654
-49,980
27,617
37,706
46,935
-16,281
234,848
Creditors
-100,535
-122,622
-83,872
290,844
-17,935
25,780
-10,503
-50,927
-220,100
203,428
-105,427
-20,720
141,717
-4,120
306,284
Accruals and Deferred Income
-135,392
20,157
2,713
516
-26,956
138,962
Deferred Taxes & Provisions
Cash flow from operations
-93,918
-43,427
44,791
428,472
137,290
-5,284
106,609
-168,362
111,024
279,890
-6,178
-29,464
110,326
45,666
43,395
Investing Activities
capital expenditure
16,256
-4,868
-161,594
167,053
4,207
-251,145
-26,359
23,648
-23,068
-14,115
-10,987
-52,097
-25,189
-16,872
-50,153
Change in Investments
cash flow from investments
16,256
-4,868
-161,594
167,053
4,207
-251,145
-26,359
23,648
-23,068
-14,115
-10,987
-52,097
-25,189
-16,872
-50,153
Financing Activities
Bank loans
Group/Directors Accounts
Other Short Term Loans
Long term loans
Hire Purchase and Lease Commitments
-157,628
-54,898
192,597
12,333
-10,840
18,436
other long term liabilities
-24,339
-25,808
60,636
-8,539
-5,989
-15,139
12,659
7,427
2,825
6,756
share issue
100
98
2
interest
34,962
35,925
9,511
-934
-1,195
2,195
1,382
767
1,673
772
201
453
391
79
cash flow from financing
10,623
10,217
70,147
-158,562
-56,093
194,792
13,715
-10,073
11,570
-5,217
-14,938
13,112
7,916
2,904
6,758
cash and cash equivalents
cash
-67,039
-38,078
-46,656
386,963
135,403
-61,637
93,965
-154,787
99,526
260,558
-32,103
-68,449
93,053
31,699
overdraft
-50,000
50,000
change in cash
-67,039
-38,078
-46,656
436,963
85,403
-61,637
93,965
-154,787
99,526
260,558
-32,103
-68,449
93,053
31,699
dermapure limited Credit Report and Business Information
Very Low Risk70 - 100
Low Risk50 - 70
Moderate Risk30 - 50
High Risk20 - 30
Very High Risk0 - 20
Get a comprehensive credit check for dermapure limited. Get real-time insights into dermapure limited's credit score, group structure and payment trends.
Perform a competitor analysis for dermapure limited by selecting its closest rivals, whether from the PROFESSIONAL, SCIENTIFIC AND TECHNICAL ACTIVITIES sector, other small companies, companies in KT13 area or any other competitors across 12 key performance metrics.
74909 - Other professional, scientific and technical activities (not including environmental consultancy or quantity surveying) n.e.c.
incorporation date
December 2005
age
20
incorporated
UK
ultimate parent company
None
accounts
Total Exemption Full
last accounts submitted
June 2024
previous names
start network limited (January 2006)
accountant
-
auditor
-
address
unit 2 trade city avro way, brooklands business park, weybridge, surrey, KT13 0YF
Bank
-
Legal Advisor
-
dermapure limited Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We found 5 charges/mortgages relating to dermapure limited. Currently there are 4 open charges and 1 have been satisfied in the past.
dermapure limited Capital Raised & Share Issues BETA
When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.
Click to start generating capital raising & share issue transactions for DERMAPURE LIMITED. This can take several minutes, an email will notify you when this has completed.
dermapure limitedCompanies House Filings - See Documents
